Gossamer Bio Stock Analysis

Gossamer Stock Analysis Notes

About 78.0% of the company shares are owned by institutional investors. The book value of Gossamer Bio was currently reported as 0.24. The company recorded a loss per share of 0.25. Gossamer Bio had not issued any dividends in recent years. Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California. Gossamer Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 185 people. To learn more about Gossamer Bio call the company at 858 684 1300 or check out https://www.gossamerbio.com.

Gossamer Bio Investment Alerts

Gossamer Bio Upcoming and Recent Events

Gossamer Largest EPS Surprises

View All Earnings Estimates

Gossamer Stock Institutional Investors

Note, although Gossamer Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Gossamer Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 218.38 M.

Gossamer Profitablity

The company has Profit Margin (PM) of (0.68) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (3.58) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $3.58.

Management Efficiency

Gossamer Bio has return on total asset (ROA) of (0.1124) % which means that it has lost $0.1124 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9026) %, meaning that it created substantial loss on money invested by shareholders. Gossamer Bio's management efficiency ratios could be used to measure how well Gossamer Bio manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.54 in 2025. Return On Capital Employed is likely to gain to -0.77 in 2025. At this time, Gossamer Bio's Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 923.7 K in 2025, whereas Total Assets are likely to drop slightly above 293.4 M in 2025.

Technical Drivers

As of the 31st of January, Gossamer Bio retains the Market Risk Adjusted Performance of 1.35, downside deviation of 4.17, and Risk Adjusted Performance of 0.0442. Gossamer Bio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Gossamer Bio variance and potential upside to decide if Gossamer Bio is priced fairly, providing market reflects its last-minute price of 0.96 per share. Given that Gossamer Bio is a hitting penny stock territory we urge to closely look at its total risk alpha.

Gossamer Bio Price Movement Analysis

Gossamer Bio Insider Trading Activities

Gossamer Bio Outstanding Bonds

Gossamer Bio Predictive Daily Indicators

Gossamer Bio Forecast Models

Gossamer Bio's time-series forecasting models are one of many Gossamer Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Gossamer Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Gossamer Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Gossamer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Gossamer Bio. By using and applying Gossamer Stock analysis, traders can create a robust methodology for identifying Gossamer entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Gossamer analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Gossamer analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Gossamer Bio stock analysis indicators help investors evaluate how Gossamer Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Gossamer Bio shares will generate the highest return on investment. By understating and applying Gossamer Bio stock analysis, traders can identify Gossamer Bio position entry and exit signals to maximize returns.

When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.